113 related articles for article (PubMed ID: 2080259)
1. [Cell kinetic investigations in fibrocystic mastopathies and invasive breast carcinomas].
Kunz J
Acta Histochem Suppl; 1990; 39():175-9. PubMed ID: 2080259
[TBL] [Abstract][Full Text] [Related]
2. [Ki 67 growth fraction in carcinomas and benign lesions of the breast].
Kunz J; Schmidt A
Zentralbl Pathol; 1993 Aug; 139(3):201-5. PubMed ID: 8218121
[TBL] [Abstract][Full Text] [Related]
3. [S-phase fraction of benign mastopathies and breast carcinomas].
Kunz J; Winzer KJ
Zentralbl Chir; 1991; 116(7):483-6. PubMed ID: 1647602
[TBL] [Abstract][Full Text] [Related]
4. [Detection of steroid hormone receptors in patients with mastopathies and fibroadenomas].
Meissner J; Kasch R; Splitt G; Gerber B; Rhode E
Zentralbl Gynakol; 1989; 111(23):1562-6. PubMed ID: 2624008
[TBL] [Abstract][Full Text] [Related]
5. Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma.
Khalifeh IM; Albarracin C; Diaz LK; Symmans FW; Edgerton ME; Hwang RF; Sneige N
Am J Surg Pathol; 2008 Apr; 32(4):544-52. PubMed ID: 18300793
[TBL] [Abstract][Full Text] [Related]
6. Reduction in apoptosis relative to mitosis in histologically normal epithelium accompanies fibrocystic change and carcinoma of the premenopausal human breast.
Allan DJ; Howell A; Roberts SA; Williams GT; Watson RJ; Coyne JD; Clarke RB; Laidlaw IJ; Potten CS
J Pathol; 1992 May; 167(1):25-32. PubMed ID: 1625055
[TBL] [Abstract][Full Text] [Related]
7. [Carcinoma arising within mammary fibroadenomas. A study of six patients].
Tissier F; De Roquancourt A; Astier B; Espie M; Clot P; Marty M; Janin A
Ann Pathol; 2000 Mar; 20(2):110-4. PubMed ID: 10740004
[TBL] [Abstract][Full Text] [Related]
8. [Pathology of premalignant and malignant diseases of the female breast].
Prechtel K
Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir; 1989; ():897-900. PubMed ID: 2577661
[TBL] [Abstract][Full Text] [Related]
9. Cell kinetics in selection and stratification of patients for adjuvant therapy of breast carcinoma.
Meyer JS
NCI Monogr; 1986; (1):25-8. PubMed ID: 3774013
[TBL] [Abstract][Full Text] [Related]
10. A technique for automatic/interactive assessment of the proliferating fraction of neoplastic cells in solid tumors. A methodological study on the Ki-67 immunoreactive cells in human mammary carcinomas, including a comparison with the results of conventional S-phase fraction assessments by means of DNA cytometry.
Parrado C; Falkmer UG; Höög A; Falkmer S; Ahrens O; Rius F; Grimelius L
Gen Diagn Pathol; 1996 Mar; 141(3-4):215-27. PubMed ID: 8705786
[TBL] [Abstract][Full Text] [Related]
11. Localization of mineralocorticoid receptor and 11 beta-hydroxysteroid dehydrogenase type II in human breast and its disorders.
Sasano H; Frost AR; Saitoh R; Matsunaga G; Nagura H; Krozowski ZS; Silverberg SG
Anticancer Res; 1997; 17(3C):2001-7. PubMed ID: 9216657
[TBL] [Abstract][Full Text] [Related]
12. [Functional morphology of breast APUD cells in dysplasia and neoplastic processes].
Sheĭnina LI; Kutivadze DA; Sulava TA; Gabuniia UA; Kvetnoĭ IM
Arkh Patol; 1989; 51(2):63-7. PubMed ID: 2565714
[TBL] [Abstract][Full Text] [Related]
13. Feulgen DNA cytophotometry in histologic sections of mammary neoplasms.
Berryman I; Sterrett GF; Papadimitriou JM
Anal Quant Cytol; 1984 Mar; 6(1):19-23. PubMed ID: 6732070
[TBL] [Abstract][Full Text] [Related]
14. Breast lobular carcinoma in a fibroadenoma.
Betta PG; Cosimi MF
Eur J Surg Oncol; 1985 Sep; 11(3):283-5. PubMed ID: 4029410
[TBL] [Abstract][Full Text] [Related]
15. Breast carcinoma cell kinetics, morphology, stage, and host characteristics. A thymidine labeling study.
Meyer JS; Prey MU; Babcock DS; McDivitt RW
Lab Invest; 1986 Jan; 54(1):41-51. PubMed ID: 3941541
[TBL] [Abstract][Full Text] [Related]
16. Her2/neu analysis in formalin-fixed, paraffin-embedded breast carcinomas: comparison of immunohistochemistry and multiparameter DNA flow cytometry.
Leers MP; Hoop JG; Nap M
Anticancer Res; 2003; 23(2A):999-1006. PubMed ID: 12820338
[TBL] [Abstract][Full Text] [Related]
17. A comparison of human breast cancer cell kinetics measured by flow cytometry and thymidine labeling.
McDivitt RW; Stone KR; Craig RB; Meyer JS
Lab Invest; 1985 Mar; 52(3):287-91. PubMed ID: 2983150
[TBL] [Abstract][Full Text] [Related]
18. Correlation between MIB-1 and other proliferation markers: clinical implications of the MIB-1 cutoff value.
Spyratos F; Ferrero-Poüs M; Trassard M; Hacène K; Phillips E; Tubiana-Hulin M; Le Doussal V
Cancer; 2002 Apr; 94(8):2151-9. PubMed ID: 12001111
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathologic analysis of breast lesions associated with multiple papillomas.
Ali-Fehmi R; Carolin K; Wallis T; Visscher DW
Hum Pathol; 2003 Mar; 34(3):234-9. PubMed ID: 12673557
[TBL] [Abstract][Full Text] [Related]
20. A method for dissociation of viable human breast cancer cells that produces flow cytometric kinetic information similar to that obtained by thymidine labeling.
McDivitt RW; Stone KR; Meyer JS
Cancer Res; 1984 Jun; 44(6):2628-33. PubMed ID: 6327021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
